Vertex's Next Steps Closely Watched Following Merck-Roche Deal On Victrelis

All eyes are on Vertex Pharmaceuticals and whether it will change course and seek a marketing partner following the May 17 announcement that Merck and Roche will co-promote Merck’s newly approved hepatitis C drug Victrelis (boceprevir).

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet